Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Ginkgo Bioworks Holdings, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $369.10M | $362.97M - $375.23M | -$369.10M | -$2.24 | 1 |
| Dec 2028 | $296.40M | $291.48M - $301.32M | -$296.40M | -$3.18 | 1 |
| Dec 2027 | $130.93M | $128.76M - $133.11M | -$130.93M | -$3.767 | 1 |
| Dec 2026 | $123.10M | $121.06M - $125.14M | -$123.10M | -$4.327 | 1 |
| Dec 2025 | $173.86M | $170.98M - $176.75M | -$173.86M | -$5.64 | 2 |
| Dec 2024 | $227.75M | $227.63M - $227.86M | -$227.75M | -$10.08 | 4 |
| Dec 2023 | $184.34M | $181.28M - $187.39M | -$184.34M | -$17.98 | 3 |
| Dec 2022 | $471.16M | $445.80M - $485.02M | -$471.16M | -$55.63 | 2 |
| Dec 2021 | $251.52M | $237.98M - $258.91M | -$251.52M | -$7.90 | 3 |